|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 51.80 GBX | +0.10% |
|
+0.10% | +8.82% |
| 03-20 | Hansard Global receives £2.1 mln from insurers for legacy litigation costs | RE |
| 03-05 | EARNINGS AND TRADING: MicroSalt wins order; Seraphim NAV up | AN |
| Market Cap | 70.66M 93.83M 82.38M 75.83M 133M 8.92B 136M 912M 353M 4.38B 352M 345M 15.24B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 70.66M 93.83M 82.38M 75.83M 133M 8.92B 136M 912M 353M 4.38B 352M 345M 15.24B | EV / Sales 2026 * |
0.76x | EV / Sales 2027 * | 0.69x |
| Free-Float |
45.49% | Yield 2026 * |
8.6% | Yield 2027 * | 8.6% |
| 1 day | +0.10% | ||
| 1 week | +0.10% | ||
| Current month | +1.07% | ||
| 1 month | -4.07% | ||
| 3 months | +9.28% | ||
| 6 months | +5.93% | ||
| Current year | +8.82% |
| 1 week | 48.63 |  | 53.5 |
| 1 month | 48.2 | | 56 |
| Current year | 46 | | 56 |
| 1 year | 43.2 | | 56 |
| 3 years | 37.2 | | 56 |
| 5 years | 32.4 | | 62.64 |
| 10 years | 23.4 | | 142.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Morfett
CEO | Chief Executive Officer | - | 02/08/2024 |
Ollie Byrne
DFI | Director of Finance/CFO | - | 01/10/2024 |
John Whitehouse
COO | Chief Operating Officer | - | 01/07/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Polonsky
BRD | Director/Board Member | - | 26/09/2018 |
Philip Kay
CHM | Chairman | 70 | 01/05/2022 |
Ollie Byrne
BRD | Director/Board Member | - | 01/10/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/10/25 | Sell | Chief Financial Officer | 35,714 | 0.0260% | ||
| 23/05/23 | Free | Chief Executive Officer | 74,899 | 0.0544% | ||
| 20/05/22 | Sell | Head of Human Resources | 18,000 | 0.0131% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.10% | +0.10% | +5.93% | +12.85% | 93.83M | |
| +5.33% | -1.40% | +52.11% | +108.00% | 144B | |
| -0.60% | +2.07% | -9.79% | +37.38% | 57.84B | |
| -5.41% | -8.92% | +50.92% | +127.69% | 53.84B | |
| +3.18% | +2.47% | +65.86% | +114.83% | 36.51B | |
| +0.50% | -0.44% | +36.51% | +123.07% | 22.64B | |
| -0.36% | +2.26% | -3.90% | +37.48% | 18.9B | |
| -1.39% | -5.03% | +86.21% | +130.51% | 15.07B | |
| +1.85% | +4.56% | +52.77% | +130.51% | 14.23B | |
| +0.78% | +2.52% | +44.17% | +64.27% | 13.98B | |
| Average | +0.40% | -2.21% | +38.08% | +88.66% | 37.72B | |
| Weighted average by Cap. | +1.54% | -5.19% | +41.12% | +98.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 93.06M 124M 108M 99.87M 176M 11.75B 179M 1.2B 465M 5.77B 464M 454M 20.07B | 102M 136M 119M 110M 193M 12.92B 197M 1.32B 512M 6.34B 510M 499M 22.08B |
| Net income | - | - |
| Net Debt | - | - |
Employees
181
Sector
Life & Health Insurance
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | GBX 51.80 | +0.10% | 6,861 |
| 01/07/26 | GBX 51.75 | +0.98% | 2,517 |
| 30/06/26 | GBX 51.25 | 0.00% | 44,099 |
| 29/06/26 | GBX 51.25 | 0.00% | 28,370 |
| 26/06/26 | GBX 51.25 | -0.97% | 24,126 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5175GBP
Average target price
0.6500GBP
Spread / Average Target
+25.60%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HSD Stock
Select your edition
All financial news and data tailored to specific country editions
